(Date:11/20/2009)...EGO, Nov. 20 Veridiam (www.veridia...d-size company category at the 2009 Workplace Exce... Diego Society for Human Resources Management and ...es practices. ,, Veridiam was one of nine winne... companies, honored at the recent awards ceremony....
(Date:11/20/2009)... METTLER TOLEDO recently announced that a ...timization Using At-Line Particle Characterization...n this webinar, the application of in situ particl...gn space and optimize a series of roller compactio...d roller compaction forces. , ...
(Date:11/19/2009)...LT, N.Y., Nov. 19 Dr. Mate Hidvegi... responds to a press release issued on November 17...pany for making false and self-serving statements ..., Dr. Hidvegi stated from his office in Budapes...arch on Avemar does not apply to AveULTRA, www.a...
(Date:11/19/2009)... MUNSTER, Germany, November 19 MON...on November 16th, 2009 Flibanserin in the,indicati...in Parkinson,s,disease for orphan drug status desi... Levodopa-induced dyskinesia is a complication of ... a serious burden to some of those,affected, since...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Roller Compaction Process Optimization Using At-Line Particle Characterization 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2...is. - ProHealth Care , a not-for-profit network ...loyed an application delivery system from NetScal...ProHealthCare selected the system to better coordi...s network of more than 700 physicians and two regi...th care services. , ,System architect William Bail...
...s. - At least six Wisconsin biotech companies wil...n event that may be another signal of the rising i...ate forums. , ,The Wisconsin companies will travel...ca VentureForum , sponsored by the Biotechnology ...iness plans and technology developments to venture...
...s. - The natural world has been medicine,s most e...s and our most potent anti- cancer drugs. , ,Now, ..., a consortium of University of Wisconsin-Madison ...rug discovery by copying and improving nature,s de...ast, cervical and pancreatic cancer. , ,The new ef...
Other Biology Technology:Six Wisconsin firms to present at BIO Mid-America VentureForum 2Six Wisconsin firms to present at BIO Mid-America VentureForum 3UW-Madison scientists to mimic nature for newest cancer drugs 2UW-Madison scientists to mimic nature for newest cancer drugs 3(Date:11/20/2009)... a single bacterial gene into yeast, researchers f...nds achieved three improvements in bioethanol prod...anol, less acetate and elimination of the major by...lished in the scientific journal Applied and Envi...anol is made by the yeast Saccharomyces cerevisiae...
(Date:11/20/2009)... production of flax shives, and generated from Br...to those which engulf fields in spring, can be use...y two studies carried out by Spanish and Dutch res...nd Sustainable Energy Reviews . , "These studies ... production of bioethanol from two, as yet unexplo...
(Date:11/20/2009)...w study, researchers report that a class of heart ...l, or harmful, effect on the heart, depending on t...ars in the journal Circulation Research , found t...beta-receptors on the heart muscle offer the most ...et only the beta-receptors can actually undermine ...
Breaking Biology News(10 mins):Delft breakthrough in bioethanol production from agricultural waste 2Flax and yellow flowers can produce bioethanol 2Carvedilol shown to have unique characteristics among beta blockers 2Spectral announces second quarter 2009 results 13544 1Spectral announces second quarter 2009 results 13544 2Spectral announces second quarter 2009 results 13544 3Spectral announces second quarter 2009 results 13544 4Spectral announces second quarter 2009 results 13544 5Spectral announces second quarter 2009 results 13544 6Spectral announces second quarter 2009 results 13544 7Spectral announces second quarter 2009 results 13544 8OncoGenex Expands Clinical Development of OGX 427 with a Phase 1 Clinical Trial in Bladder Cancer 4850 1OncoGenex Expands Clinical Development of OGX 427 with a Phase 1 Clinical Trial in Bladder Cancer 4850 2OncoGenex Expands Clinical Development of OGX 427 with a Phase 1 Clinical Trial in Bladder Cancer 4850 3OncoGenex Expands Clinical Development of OGX 427 with a Phase 1 Clinical Trial in Bladder Cancer 4850 4Massachusetts Technology Corporation Named to Inc 5000 List of Fastest Growing Private Companies 13542 1Massachusetts Technology Corporation Named to Inc 5000 List of Fastest Growing Private Companies 13542 2...umber of articles explore the use of positron emis...nsurgical techniques that open the door to underst...ssue of the Society of Nuclear Medicine,s Journal ...imal imaging "is the ability to carry out many stu... said SNM member Michael J. Welch, Ph.D., co-autho...
...logists at Lehigh University and the University of...ii,s forests as the world,s fastest-evolving inver...the driving force behind the speedy speciation of ...an. 27 issue of Nature magazine. , Females in the...e rates of male courtship songs, which differ from...
...eam of researchers led by University of Illinois a... a decline in life expectancy in the United States...based on the dramatic rise in obesity, especially ...al report appearing in the March 17 issue in the N...ines that obesity currently reduces life expectanc...
Other Biology News:Use of PET can reduce, may eliminate more strenuous drug development trials with animals 2Use of PET can reduce, may eliminate more strenuous drug development trials with animals 3Use of PET can reduce, may eliminate more strenuous drug development trials with animals 4Cricket's finicky mating behavior boosts biodiversity 2Cricket's finicky mating behavior boosts biodiversity 3US life expectancy about to decline, researchers say 2US life expectancy about to decline, researchers say 3Cellject Duo include instruction manual, optimization guide and 10 cuvettes, 110 V from Thermo Scientific
Reverse Transcriptase AMV; RNA dependent DNA polymerase from Roche Applied Science
AMV Reverse Transcriptase from Promega
DNase I, RNase-free; special quality for molecular biology from Roche Applied Science
Biology Products: